Viridian Therapeutics
VRDN
#4803
Rank
A$2.41 B
Marketcap
$30.44
Share price
1.60%
Change (1 day)
-7.82%
Change (1 year)

Viridian Therapeutics (VRDN) - Cash on Hand

Cash on Hand as of September 2024 : A$1.20 Billion

According to Viridian Therapeutics's latest financial reports the company has A$1.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viridian Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.70 B12.31%
2022-12-31A$0.62 B129.63%
2021-12-31A$0.27 B63.67%
2020-12-31A$0.16 B332.93%
2019-12-31A$38.34 M-56.77%
2018-12-31A$88.69 M45.95%
2017-12-31A$60.76 M1211.06%
2016-12-31A$4.63 M-68.83%
2015-12-31A$14.86 M137.72%
2014-12-31A$6.25 M2569.5%
2013-12-31A$0.23 M116.37%
2012-12-31A$0.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B-63.84%๐Ÿ‡บ๐Ÿ‡ธ USA